Drugstore chain Rite Aid Corporation (NYSE: RAD) announced fourth-quarter 2023 results, reporting a modest increase in revenues and a narrower net loss.
Fourth-quarter loss, excluding special items, improved to $1.24 per share from a loss of $2.24 per share in the same period of last year. On a reported basis, the net loss attributable to common stockholders was $241.3 million or $4.39 per share, compared to a loss of $389.1 million or $7.18 per share in the prior-year quarter.
Total revenues increased modestly to $6.09 billion in the fourth quarter from $6.07 billion in the corresponding period of 2022. Retail comparable same-store prescriptions moved up 5.2% while comparable same-store prescriptions, excluding COVID impacts, increased 9.7%.
“We are making progress in our turnaround program to drive performance acceleration that we expect will help mitigate fiscal 2024 challenges related to reimbursement, COVID headwinds, and enrollment at Elixir, and to drive meaningful Adjusted EBITDA growth in fiscal 2025 and 2026,” said interim chief executive officer Elizabeth Burr.
Most Popular
Important takeaways from Broadcom’s (AVGO) Q4 2023 earnings
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) ended fiscal 2023 on a positive note, delivering strong results for the fourth quarter. In the new fiscal year, the company’s focus will be
Here’s what Signet Jewelers (SIG) expects for the holiday season and beyond
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 2% on Friday. The stock has gained 40% year-to-date and 27% over the past three months. The jewelry retailer saw
DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates
eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and
